Mraz Amerine & Associates Inc. Boosts Stake in Cameco Co. (NYSE:CCJ)

Mraz Amerine & Associates Inc. grew its stake in shares of Cameco Co. (NYSE:CCJ) (TSE:CCO) by 3.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 9,022 shares of the basic materials company’s stock after buying an additional 275 shares during the quarter. Mraz Amerine & Associates Inc.’s holdings in Cameco were worth $389,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in CCJ. Morgan Stanley grew its holdings in shares of Cameco by 5.8% during the 3rd quarter. Morgan Stanley now owns 7,752,258 shares of the basic materials company’s stock valued at $307,300,000 after purchasing an additional 428,310 shares during the last quarter. Guardian Capital LP lifted its position in shares of Cameco by 40.7% in the 3rd quarter. Guardian Capital LP now owns 864,304 shares of the basic materials company’s stock worth $34,451,000 after purchasing an additional 250,115 shares during the period. Foster Victor Wealth Advisors LLC purchased a new stake in shares of Cameco in the 4th quarter worth about $3,956,000. Financial Insights Inc. purchased a new stake in shares of Cameco in the 3rd quarter worth about $1,942,000. Finally, Platinum Investment Management Ltd. lifted its position in shares of Cameco by 156.3% in the 3rd quarter. Platinum Investment Management Ltd. now owns 3,089,235 shares of the basic materials company’s stock worth $122,605,000 after purchasing an additional 1,884,004 shares during the period. Hedge funds and other institutional investors own 70.21% of the company’s stock.

Cameco Price Performance

Shares of CCJ stock traded up $0.22 during mid-day trading on Wednesday, hitting $48.41. The company had a trading volume of 2,665,488 shares, compared to its average volume of 5,244,856. Cameco Co. has a 52-week low of $25.11 and a 52-week high of $52.64. The stock’s 50 day moving average price is $43.65 and its 200-day moving average price is $43.39. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.55 and a quick ratio of 0.97. The company has a market capitalization of $21.02 billion, a P/E ratio of 80.32 and a beta of 0.92.

Cameco (NYSE:CCJ) (TSE:CCO) last released its earnings results on Thursday, February 8th. The basic materials company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.06). The company had revenue of $620.00 million during the quarter. Cameco had a return on equity of 5.61% and a net margin of 13.97%. Equities research analysts forecast that Cameco Co. will post 1.55 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Cantor Fitzgerald cut shares of Cameco from a “buy” rating to a “neutral” rating in a research report on Tuesday, December 19th. StockNews.com cut shares of Cameco from a “hold” rating to a “sell” rating in a report on Thursday, April 4th. Finally, The Goldman Sachs Group assumed coverage on shares of Cameco in a report on Monday, April 1st. They issued a “buy” rating and a $55.00 target price for the company. One analyst has rated the stock with a sell rating, one has assigned a hold rating, two have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $62.75.

Cameco Company Profile

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.